University College London (UCL)
UCL is a major hub for cancer research, combining computational and data infrastructure, deeply phenotyped cancer cohorts and world-class imaging science to advance early detection approaches.
About the centre
UCL has been a member of the International Alliance for Cancer Early Detection (ACED) since our launch in 2019. It provides rich clinical imaging archives from early detection cohorts, an invaluable asset for our research network.
The ACED centre at UCL unites world‑class imaging science with rich biomarker data to sharpen image-based early prediction and prognosis tools. By building infrastructure to share imaging, biomarker and clinical‑outcome data from over 200,000 people, the centre is creating a powerful resource to drive the next generation of early‑detection strategies across the Alliance.
UCL is a global leader in combining deep learning and AI methodologies with dedicated state-of-the-art imaging to enhance the sensitivity and specificity of our novel early detection strategies. The centre provides dedicated computational resources with imaging technologies and expertise for the integration of imaging and non-imaging biomarkers, maximising image-derived prediction and prognosis.
Learn more about UCLCore expertise and resources
high-performance computational resources for early detection research
advanced imaging technologies and expertise, including dedicated research scanners and collaboration with Cancer Research UK’s National Cancer Imaging Translational Accelerator (NCITA)
virtual disease frameworks that simulate tumours, tissue microenvironments and histological features
extensive early detection cohorts that are accessible across the Alliance
Key contacts
Mark Emberton
UCL ACED Centre Director
Aleksandra Gentry-Maharaj
UCL ACED Centre Deputy Director
Louise Urien
UCL ACED Centre Programme Manager